The FDA recently approved an at-home test that allows a person to test the likelihood of getting breast cancer.
It's called 23andMe. It tests three DNA mutations, and user won't need a prescription to use it.
“These three mutations, however, are not the most common BRCA1/BRCA2 mutations in the general population." FDA
The test uses a saliva sample to get results.